LAURA BIEHLE: Open Payments
NPI 1932762218 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,495 in 96 payments from 13 companies in 2025. Trend: 2023 $11,297 · 2024 $7,422 · 2025 $10,495
Speaker / faculty: $7,106Food & beverage: $2,088Travel & lodging: $1,291Education: $10
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 36 | $9,203 |
| GENZYME CORPORATION | 6 | $353 |
| ABBVIE INC. | 18 | $308 |
| Janssen Biotech, Inc. | 15 | $182 |
| Regeneron Healthcare Solutions, Inc. | 7 | $167 |
| LEO Pharma Inc. | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Amgen Inc. | 3 | $36 |
| Galderma Laboratories, L.P. | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, ADBRY, Otezla, Rhapsido.
Industry payments across NV — which companies pay providers there.
